CHARACTERISTICS OF STENOTROPHOMONAS MALTOPHILIA ISOLATES FROM CYSTIC FIBROSIS PATIENTS IN RUSSIA

Stenotrophomonas maltophilia is a common opportunistic microorganism and an important respiratory pathogen in cystic fibrosis (CF). The aim of this study was to determine antimicrobial resistance phenotypes, sequence-types (ST) and genetic determinants of antibiotic resistance in S. maltophilia strains recovered from CF patients in Russia. S. maltophilia isolates recovered from 170 CF patients were analyzed. Minimum inhibitory concentrations of antibacterial agents were determined using Sensititre Gram Negative GNX2F plates and the results were interpreted according to Clinical and Laboratory Standards Institute (CLSI) criteria. Whole-genome sequencing (WGS) was performed on MGISEQ-2000 platform. SPAdes software, Galaxy, ResFinder, Integrall and PubMLST were used for analysis of WGS data. S. maltophilia strains were identified from 24/170 (14%) CF patients. In total, 25 isolates were detected, two strains were isolated from the same patient. The isolates belonged to 17 different STs, including 5 new STs; ST4 was the most prevalent ST. Resistance to ceftazidime was observed in 60% of strains, to ticarcillin-clavulanate - in 32%, to levofloxacin - in 24%, to trimethoprim/sulfamethoxazole - in 12% of strains. All isolates were susceptible to minocycline. All ST4 isolates were resistant or intermediate to ceftazidime and ticarcillin-clavulanate. In two isolates, the sul1 gene was detected. In one isolate, sul1 was part of a class 1 integron. The detected integron also contained the blaGES-7 and aac(6’)-Ib-cr genes. The ST4 sequence-type was the most prevalent ST among S. maltophilia strains recovered from CF patients in Russia. Antibiotic resistance genes, including sul1, blaGES-7, aac(6’)-Ib-cr, were detected in single strains.

Panina M.V., Klyasova G.A., Novichkova G.A., Baidildina D.D., Litvinov D.V., Goronkova O.V. et al. Clinical manifestations and outcome of Stenotrophomonas maltophilia bacteremia in children with hematological and oncological deseases. Voprosy gematologii/onkologii i immunopatologii v pediatrii. 2014; 13(2): 31-41. (in Russian)

Reynaud Q., Weber E., Gagneux-Brunon A., Suy F., Romeyer-Bouchard C., Lucht F. et al. Late Stenotrophomonas maltophilia pacemaker infective endocarditis. Med. Mal. Infect. 2015; 45(3): 95-7. https://doi.org/10.1016/j.medmal.2015.01.016

Wang C.H., Hsu S.W., Tsai T.H., Wang N.C. An outbreak of trimethoprim/sulfamethoxazole–resistant Stenotrophomonas maltophilia meningitis associated with neuroendoscopy. J. Med. Sci. 2014; 34(5): 235–7. https://doi.org/10.4103/1011-4564.143653

Millan-Diaz B., Gonzalez-Tabares L., Cobelo-Casas C., Lopez-Vazquez M., Calvino-Varela J. Stenotrophomonas maltophilia: A rare cause of peritonitis in capd patients. Nefrologia. 2017; 37(6): 646-7. https://doi.org/10.1016/j.nefro.2017.03.018

Waters V., Atenafu E.G., Lu A., Yau Y., Tullis E., Ratjen F. Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients. J. Cyst. Fibros. 2013; 12(5): 482-6. https://doi.org/10.1016/j.jcf.2012.12.006

Adegoke A.A., Stenstrom T.A., Okoh A.I. Stenotrophomonas maltophilia as an emerging ubiquitous pathogen: looking beyond contemporary antibiotic therapy. Front. Microbiol. 2017; 8: 2276. https://doi.org/10.3389/fmicb.2017.02276

Menetrey Q., Sorlin P., Jumas-Bilak E., Chiron R., Dupont C., Marchandin H. Achromobacter xylosoxidans and Stenotrophomonas maltophilia: emerging pathogens well-armed for life in the cystic fibrosis patients’ lung. Genes (Basel). 2021; 12(5): 610. https://doi.org/10.3390/genes12050610

European Committee on Antimicrobial Susceptibility Testing (EUCAST). Intrinsic Resistance and Unusual Phenotypes. Version 3.3, October 2021. Available at: https://www.eucast.org/expert_rules_and_intrinsic_resistance/ (accessed: February 2022).

Zając O.M., Tyski S., Laudy A.E. Phenotypic and molecular characteristics of the MDR efflux pump gene-carrying Stenotrophomonas maltophilia strains isolated in Warsaw, Poland. Biology. 2022; 11(1): 105. https://doi.org/10.3390/biology11010105

Baseri Z., Dehghan A., Yaghoubi S., Razavi S. Prevalence of resistance genes and antibiotic resistance profile among Stenotrophomonas maltophilia isolates from hospitalized patients in Iran. New Microbes New Infect. 2021; 44:100943. https://doi.org/10.1016/j.nmni.2021.100943

Esposito A., Pompilio A., Bettua C., Crocetta V., Giacobazzi E., Fiscarelli E. et al. Evolution of Stenotrophomonas maltophilia in cystic fibrosis lung over chronic infection: a genomic and phenotypic population study. Front. Microbiol. 2017; 8: 1590. https://doi.org/10.3389/fmicb.2017.01590

Russian Association for patients with cystic fibrosis. Available at: https://mukoviscidoz.org/doc/registr/site_Registre_2019.pdf (accessed: January 2022). (in Russian)

Clinical and Laboratory Standards Institute (CLSI). Available at: http://em100.edaptivedocs.net/dashboard.aspx (accessed: January 2022).

Bankevich A., Nurk S., Antipov D., Gurevich A.A., Dvorkin M., Kulikov A.S. et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J. Comput. Biol. 2012; 19(5): 455-77. https://doi.org/10.1089/cmb.2012.0021

Lee I., Chalita M., Ha S.M., Na S.I., Yoon S.H., Chun J. ContEst16S: an algorithm that identifies contaminated prokaryotic genomes using 16S RNA gene sequences. Int. J. Syst. Evol. Microbiol. 2017; 67(6): 2053-7. https://doi.org/10.1099/ijsem.0.001872

Parks D.H., Imelfort M., Skennerton C.T., Hugenholtz P., Tyson G.W. CheckM: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes. Genome Res. 2015; 25(7): 1043-55. https://doi.org/10.1101/gr.186072.114

Gurevich A., Saveliev V., Vyahhi N., Tesler G. QUAST: quality assessment tool for genome assemblies. Bioinformatics. 2013; 29(8): 1072-5. https://doi.org/10.1093/bioinformatics/btt086

ResFinder 4.1. Available at: https://cge.cbs.dtu.dk/services/ResFinder (accessed: January 2022).

Galaxy. Available at: https://usegalaxy.org/ (accessed: January 2022).

Integrall. The Integron Database. Available at: http://integrall.bio.ua.pt/ (accessed: January 2022).

Public databases for molecular typing and microbial genome diversity (PubMLST). Available at: https://pubmlst.org/bigsdb?db=pubmlst_smaltophilia_seqdef (accessed: January 2022).

Cystic Fibrosis Foundation. 2019 Patient registry annual data report. Available at: https://www.cff.org/sites/default/files/2021-10/2019-Patient-Registry-Annual-Data-Report.pdf (accessed: January 2022).

European Cystic Fibrosis Society Patient Registry Annual Data report 2019. Available at: https://www.ecfs.eu/sites/default/files/general-content-images/working-groups/ecfs-patient-registry/ECFSPR_Report_2019_v1_23Dec2021.pdf (accessed: January 2022).

Public databases for molecular typing and microbial genome diversity (PubMLST). Stenotrophomonas maltophilia. Available at: https://pubmlst.org/bigsdb?db=pubmlst_smaltophilia_isolates&page=query (accessed: January 2022).

Corlouer C., Lamy B., Desroches M., Ramos-Vivas J., Mehiri-Zghal E., Lemenand O. et al. Stenotrophomonas maltophilia healthcare-associated infections: identification of two main pathogenic genetic backgrounds. J. Hosp. Infect. 2017; 96(2): 183-8. https://doi.org/10.1016/j.jhin.2017.02.003

Herrera-Heredia S.A., Pezina-Cantu C., Garza-Gonzalez E., Bocanegra-Ibarias P., Mendoza-Olazaran S., Morfin-Otero R. et al. Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico. J. Med. Microbiol. 2017; 66(8): 1102-9. https://doi.org/10.1099/jmm.0.000550

Blanco P., Corona F., Martinez J.L. Involvement of the RND efflux pump transporter SmeH in the acquisition of resistance to ceftazidime in Stenotrophomonas maltophilia. Sci. Rep. 2019; 9: 4917. https://doi.org/10.1038/s41598-019-41308-9

Huang H.H., Chen P.Y., Hu R.M., Lin Y.T., Li L.H., Yang T.C. Impacts of L1 promoter variation and L2 clavulanate susceptibility on ticarcillin-clavulanate susceptibility of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 2018; 62(11): e01222-18. https://doi.org/10.1128/AAC.01222-18

Azimi A., Rezaei F., Yaseri M., Jafari S., Rahbar M., Douraghi M. Emergence of fluoroquinolone resistance and possible mechanisms in clinical isolates of Stenotrophomonas maltophilia from Iran. Sci. Rep. 2021; 11: 9582. https://doi.org/10.1038/s41598-021-88977-z

Domingues S., da Silva G.J., Nielsen K.M. Integrons: Vehicles and pathways for horizontal dissemination in bacteria. Mob. Genet. Elements. 2012; 2(5): 211-23. https://doi.org/10.4161/mge.22967

The Comprehensive Antibiotic Resistance Database. Available at: https://card.mcmaster.ca/home (accessed: January 2022).

Ghaly T.M., Geoghegan J.L., Tetu S.G., Gillings MR. The peril and promise of integrons: beyond antibiotic resistance. Trends Microbiol. 2020; 28(6): 455-64. https://doi.org/10.1016/j.tim.2019.12.002